Stefan Bittner

Stefan Bittner

Department of Neurology, University of Münster

Affiliated withUniversity of MünsterInterdisciplinary Center for Clinical Research (IZKF), MünsterInterdisciplinary Center for Clinical Research (IZKF) Münster

+1

Research Area

Immunology and InfectionNeuroscience

Biography

Stefan Bittner has not added Biography.
If you are Stefan Bittner and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 3
Year
Myelin Oligodendrocyte Glycoprotein (MOG<sub>35-55</sub>) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
Publication title
2014
2014
2015

Other Publications

Article
Year
The two-pore domain potassium channel TASK3 functionally impacts glioma cell death.

Journal of neuro-oncology| PubMed ID: 18217213

2008
2008
2008
2008
2009
2009
2009
2010
Cytotoxic CD8+ T cell-neuron interactions: perforin-dependent electrical silencing precedes but is not causally linked to neuronal cell death.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 20007464

2009
2010
2010
From the background to the spotlight: TASK channels in pathological conditions.

Brain pathology (Zurich, Switzerland)| PubMed ID: 20529081

2010
2010
Therapeutic approaches to multiple sclerosis: an update on failed, interrupted, or inconclusive trials of immunomodulatory treatment strategies.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy| PubMed ID: 20623991

2010
Two pore domain potassium channels in cerebral ischemia: a focus on K2P9.1 (TASK3, KCNK9).

Experimental & translational stroke medicine| PubMed ID: 20646278

2010
2010
2010
Natalizumab restores evoked potential abnormalities in patients with relapsing-remitting multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 21135021

2011
2011
2011
2011
Ion channels in autoimmune neurodegeneration.

FEBS letters| PubMed ID: 21501610

2011
2011
IL-17 silencing does not protect nonobese diabetic mice from autoimmune diabetes.

Journal of immunology (Baltimore, Md. : 1950)| PubMed ID: 22116823

2012
2012
2012
2013
2013
2013
2013
2013
2013
Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 23959874

2013
Targeting ion channels for the treatment of autoimmune neuroinflammation.

Therapeutic advances in neurological disorders| PubMed ID: 23997817

2013
2013
2013
2013
2013
2013
TREK-King the Blood-Brain-Barrier.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology| PubMed ID: 24557892

2014
Blocking of α4 integrin does not protect from acute ischemic stroke in mice.

Stroke; a journal of cerebral circulation| PubMed ID: 24743435

2014
Human CD4+ HLA-G+ regulatory T cells are potent suppressors of graft-versus-host disease in vivo.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 24744146

2014
2014
2014
2014
2014
The two-pore domain potassium channel KCNK5 deteriorates outcome in ischemic neurodegeneration.

Pflugers Archiv : European journal of physiology| PubMed ID: 25315980

2014
The CNS under pathophysiologic attack-examining the role of K2P channels.

Pflugers Archiv : European journal of physiology| PubMed ID: 25482672

2014
Long-term efficacy of alemtuzumab in polymyositis.

Rheumatology (Oxford, England)| PubMed ID: 25552256

2014